[Simultaneous cardiac and thoracic operations].

Area of Science:

• Cardiovascular Surgery
• Thoracic Surgery
• Surgical Oncology

Background:

• Optimal surgical strategy for patients with coexisting heart disease (ischemic heart disease, valve disease) and thoracic conditions (pulmonary carcinoma) remains debated.
• The management of patients requiring simultaneous cardiac and thoracic interventions presents unique challenges.

Purpose of the Study:

• To evaluate the safety and efficacy of simultaneous cardiac and thoracic surgical procedures.
• To assess the impact of combined procedures on hospital morbidity and mortality.
• To determine if combined operations affect the initiation of subsequent oncological therapy.

Main Methods:

• A retrospective review of 13 patients who underwent simultaneous cardiac and thoracic operations between 1997 and 2004.
• Procedures included coronary artery bypass grafting (CABG), aortic valve replacement, and various lung cancer resections (lobectomy, pneumectomy, etc.).
• Surgical approaches included sternotomy and thoracotomy, with both cardiopulmonary bypass and off-pump techniques employed.

Main Results:

• No in-hospital mortality was observed among the 13 patients.
• One patient required re-exploration for bleeding; overall morbidity and mortality were comparable to cardiac surgery alone.
• Mean blood loss, intubation duration, and hospital stay were not significantly different from patients undergoing only cardiac surgery.

Conclusions:

• Combined cardiac and thoracic surgical procedures do not adversely affect hospital morbidity or mortality.
• Simultaneous operations eliminate the need for staged procedures, preventing delays in oncological treatment.
• Long-term patient outcomes are predominantly influenced by the histological characteristics and extent of the thoracic malignancy.